GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (AQSE:HCM.GB) » Definitions » Asset Impairment Charge

HUTCHMED (China) (AQSE:HCM.GB) Asset Impairment Charge : £0.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is HUTCHMED (China) Asset Impairment Charge?

HUTCHMED (China)'s Asset Impairment Charge for the six months ended in Jun. 2024 was £0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 was £0.0 Mil.


HUTCHMED (China) Asset Impairment Charge Historical Data

The historical data trend for HUTCHMED (China)'s Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Asset Impairment Charge Chart

HUTCHMED (China) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HUTCHMED (China) Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

HUTCHMED (China) Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.0 Mil.


HUTCHMED (China) Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


HUTCHMED (China) Business Description

Address
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

HUTCHMED (China) Headlines

No Headlines